iSpecimen(ISPC)
$0.71-0.03 (-3.80%)
ISPC
iSpecimen financials statements
$0.71
At close:-0.03 (-3.80%)
Want to see ISPC full AI Analyst Report?
iSpecimen (ISPC) Ratios
304 Followers
iSpecimen Ratios
ISPC's free cash flow for Q2 2026 was $-689.62K. For the 2026 fiscal year, ISPC's free cash flow was increased by $5.00 and operating cash flow was $-689.63K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 0.62 | 1.36 | 4.60 | 13.15 |
| Quick Ratio | 1.12 | 0.62 | 1.36 | 4.60 | 13.15 |
| Cash Ratio | 1.10 | 0.33 | 0.39 | 3.58 | 11.07 |
| Solvency Ratio | -1.36 | -1.69 | -1.49 | -2.10 | -1.34 |
| Operating Cash Flow Ratio | -0.68 | -1.43 | -0.96 | -1.36 | -4.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 511.41K | $ -2.45M | $ 2.16M | $ 15.37M | $ 27.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.10 |
| Debt-to-Equity Ratio | 0.09 | 0.09 | 0.02 | 0.01 | 0.11 |
| Debt-to-Capital Ratio | 0.08 | 0.09 | 0.02 | 0.01 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Financial Leverage Ratio | 3.09 | 2.82 | 1.62 | 1.21 | 1.20 |
| Debt Service Coverage Ratio | -4487.79 | -47.15 | -38.14 | -36.83 | -2.78 |
| Interest Coverage Ratio | -4606.42 | -57.84 | -48.40 | -42.63 | -2.82 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Interest Debt Per Share | 2.35 | 29.95 | 0.94 | 0.96 | 13.52 |
| Net Debt to EBITDA | 0.76 | 0.15 | 0.24 | 1.72 | 4.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 1.25% | 42.93% | 51.45% | 54.27% | 52.86% |
| EBIT Margin | -543.16% | -136.38% | -109.47% | -96.20% | -61.60% |
| EBITDA Margin | -453.43% | -111.69% | -88.67% | -84.61% | -52.58% |
| Operating Profit Margin | -465.42% | -136.99% | -112.50% | -97.92% | -53.21% |
| Pretax Profit Margin | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
| Net Profit Margin | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
| Continuous Operations Profit Margin | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 116.81% | 98.19% | 99.37% | 100.59% | 151.25% |
| Return on Assets (ROA) | -110.03% | -133.66% | -70.16% | -41.62% | -25.09% |
| Return on Equity (ROE) | -339.60% | -377.46% | -113.95% | -50.45% | -30.08% |
| Return on Capital Employed (ROCE) | -272.05% | -355.55% | -114.32% | -50.09% | -17.84% |
| Return on Invested Capital (ROIC) | -267.44% | -351.30% | -112.40% | -49.70% | -17.84% |
| Return on Tangible Assets | -122.93% | -310.77% | -129.25% | -50.94% | -27.15% |
| Earnings Yield | -876.42% | -660.97% | -245.28% | -84.36% | -14.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 39.94 | 6.43 | 3.38 | 2.65 | 2.28 |
| Payables Turnover | 0.36 | 1.26 | 1.23 | 1.93 | 6.30 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 6.55 | 22.04 | 30.87 | 25.34 | 339.69 |
| Asset Turnover | 0.20 | 0.99 | 0.63 | 0.42 | 0.31 |
| Working Capital Turnover Ratio | -2.64 | 2586.61 | 1.13 | 0.45 | 1.89 |
| Cash Conversion Cycle | -1018.40 | -232.18 | -189.12 | -50.94 | 102.13 |
| Days of Sales Outstanding | 9.14 | 56.75 | 108.12 | 137.75 | 160.04 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1027.54 | 288.93 | 297.24 | 188.68 | 57.90 |
| Operating Cycle | 9.14 | 56.75 | 108.12 | 137.75 | 160.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -36.86 | -465.01 | -12.85 | -13.17 | -26.11 |
| Free Cash Flow Per Share | -36.86 | -466.79 | -23.34 | -20.40 | -28.65 |
| Dividend Paid and CapEx Coverage Ratio | -9340.55 | -146.14 | -1.22 | -1.82 | -10.28 |
| Capital Expenditure Coverage Ratio | -9340.55 | -146.14 | -1.22 | -1.82 | -10.28 |
| Operating Cash Flow Coverage Ratio | -15.78 | -26.47 | -29.59 | -31.30 | -3.12 |
| Operating Cash Flow to Sales Ratio | -2.20 | -0.89 | -0.58 | -0.56 | -0.96 |
| Free Cash Flow Yield | -354.42% | -438.71% | -233.19% | -74.18% | -18.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.11 | -0.15 | -0.41 | -1.19 | -7.12 |
| Price-to-Sales (P/S) Ratio | 0.62 | 0.20 | 0.46 | 1.17 | 5.73 |
| Price-to-Book (P/B) Ratio | 0.39 | 0.57 | 0.46 | 0.60 | 2.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.28 | -0.23 | -0.43 | -1.35 | -5.45 |
| Price-to-Operating Cash Flow Ratio | -0.28 | -0.23 | -0.78 | -2.09 | -5.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 0.00 | 0.07 | 0.09 |
| Enterprise Value Multiple | 0.62 | -0.03 | -0.27 | 0.34 | -6.75 |
| Enterprise Value | -5.42M | 324.59K | 2.38M | -2.98M | 39.51M |
| EV to EBITDA | 0.62 | -0.03 | -0.27 | 0.34 | -6.75 |
| EV to Sales | -2.81 | 0.03 | 0.24 | -0.29 | 3.55 |
| EV to Free Cash Flow | 1.28 | -0.04 | -0.23 | 0.33 | -3.38 |
| EV to Operating Cash Flow | 1.28 | -0.04 | -0.41 | 0.51 | -3.70 |
| Tangible Book Value Per Share | 18.15 | -113.54 | 5.55 | 35.79 | 66.27 |
| Shareholders’ Equity Per Share | 26.84 | 186.32 | 21.55 | 45.99 | 72.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 16.77 | 522.82 | 21.96 | 23.55 | 27.25 |
| Net Income Per Share | -91.15 | -703.27 | -24.55 | -23.20 | -21.93 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 0.99 | 1.02 | 1.02 | 1.31 |
| Research & Development to Revenue | 1.12 | 0.38 | 0.36 | 0.26 | 0.17 |
| SG&A to Revenue | 3.42 | 1.36 | 0.78 | 0.86 | 0.63 |
| Stock-Based Compensation to Revenue | 0.01 | 0.03 | 0.05 | 0.07 | 0.06 |
| Income Quality | 0.40 | 0.66 | 0.52 | 0.57 | 1.19 |
Currency in USD
